Long term prognosis of medullary thyroid carcinoma in 39 patients

Annales Chirurgiae et Gynaecologiae

Volumn 89, Issue 4, 2000, Pages 292-297

  Voutilainen, P E ^a   Multanen, M ^a   Haapiainen, R K ^a   Haglund, C H ^a   Sane, T ^a   Sivula, A H ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Hereditary; Overadjustment; Sporadic

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PREDICTION; PROGNOSIS; SURVIVAL TIME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, MEDULLARY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 30344442834     PISSN: 03559521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Incidence of sporadic and familial medullary thyroid carcinoma in Sweden 1959 through 1981. A nationwide study in 126 patients
2. Thyroid cancer treated in Chang Gung Memorial Hospital (northern Taiwan) during the period 1979-1992: Clinical presentation, pathological finding, analysis of prognostic variables, and results of treatment
3. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973- 1991
4. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A
5. Treatment of preclinical medullary thyroid carcinoma in MEN 2A gene carrier
6. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience
7. Long-term follow-up of patients with medullary carcinoma of the thyroid
8. Medullary thyroid carcinoma: Prognosis of familial versus nonfamilial disease and the role of radiotherapy
9. German medullary thyroid carcinoma/multiple endocrine neoplasia registry
10. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: Results in 899 patients
11. The surgical management of medullary thyroid carcinoma
12. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
13. Surgical treatment of medullary carcinoma of the thyroid
14. Medullary carcinoma of the thyroid - Therapeutic strategy derived from fifteen years of experience
15. The value of lymph node dissection in hereditary medullary thyroid carcinoma: A retrospective, European, multicentre study
16. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma
17. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients
18. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels
19. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma
20. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma
21. Improved results of cervical reoperation for medullary thyroid carcinoma
22. Improved selection of patients for reoperation for medullary thyroid cancer by imaging with radiolabeled anticarcinoembryonic antigen antibodies
23. Somatostatin receptor scintigraphy in medullary thyroid carcinoma
24. Somatostatin receptor subtypes, octreotide scintigraphy, and clinical response to octreotide treatment in patients with neuroendocrine tumors
25. Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland
26. Reoperation in metastasizing medullary thyroid carcinoma: Is a tumor stage-oriented approach justified?
27. Octreotide therapy in advanced thyroid cancer
28. Thyroid gland
29. Regression models and life-tables
30. Management of occult medullary thyroid carcinoma: Evidenced only by serum calcitonin level elevations after apparently adequate neck operations
31. Improving the quality of reporting of randomized controlled trials. The CONSORT statement